Summary
A review of 51 clinical trials of antihypertensive agents suggested a method of creating simple equations to determine a patient's risk of suffering death, major cardiovascular (CV) death, or other CV disease once the patient's risk of CV mortality is known. The technique incorporated the latest ESH-ESC Hypertension Guidelines [J Hypertens 2013].
- Hypertensive Disease
- Cardiology Clinical Trials
- Hypertensive Disease
- Cardiology Clinical Trials
- Cardiology
- © 2013 MD Conference Express®
Tools
Large Study Suggests That Death Comprises Higher Proportion of Major CV Events in Patients with Greater CV Risk
Permalink:
Table of contents
Cited By...
- No citing articles found.